Table 4 Proteins with a significant change in intensity regardless of groups selected for comparison.
From: Acute and chronic blood serum proteome changes in patients with methanol poisoning
Protein | Increase or decrease in intensity (C → S → M) | Mean intensity in group C | Mean intensity in group S | Mean intensity in group M | Category of function |
|---|---|---|---|---|---|
KNG1_HUMAN Kininogen-1 (UniProt id = P01042)* | ↘ | 560E+07 | 435E+07 | 101E+07 | Blood coagulation cascade |
 ± 156E+07 |  ± 172E+07 |  ± 574E+06 | |||
KNG1_HUMAN Kininogen-1 (other isoforms, UniProt id = P01042-2, P02042-3)** | ↘ | 558E+07 | 371E+07 | 231E+07 | Blood coagulation cascade |
 ± 256E+07 |  ± 133E+07 |  ± 745E+06 | |||
KNG1_HUMAN Kininogen-1 (all isoforms) | ↘ | 112E+08 | 806E+07 | 332E+07 | Blood coagulation cascade |
 ± 320E+07 |  ± 281E+07 |  ± 995E+06 | |||
IPSP_HUMAN, G3V2M1_HUMAN: Plasma serine protease inhibitor | ? | 120E+07 | 180E+07 | 136E+06 | Plasminogen cascade |
 ± 361E+06 |  ± 895E+06 |  ± 112E+06 | |||
FGD6_HUMAN, F8VQX5_HUMAN, F8VY01_HUMAN: FYVE, RhoGEF, and PH domain-containing protein 6 | ↘ | 211E+07 | 645E+06 | 133E+06 | JNK pathway |
 ± 169E+07 |  ± 491E+06 |  ± 249E+06 | |||
AMBP_HUMAN, S4R3Y4_HUMAN: Protein AMBP; S4R471_HUMAN: Alpha-1-microglobulin | ↗ | 920E+07 | 118E+08 | 165E+08 | Heme degradation, immune system, signaling |
 ± 210E+07 |  ± 254E+07 |  ± 411E+07 | |||
APOD_HUMAN, C9JF17_HUMAN: Apolipoprotein D | ↗ | 395E+06 | 591E+06 | 105E+07 | Lipid and vitamin A metabolism, neuroprotective effects |
 ± 143E+06 |  ± 224E+06 |  ± 476E+06 | |||
CPN2_HUMAN Carboxypeptidase N subunit 2 | ↗ | 443E+07 | 617E+07 | 974E+07 | Plasminogen cascade |
 ± 139E+07 |  ± 265E+07 |  ± 369E+07 | |||
G3XAM2_HUMAN, CFAI_HUMAN, E7ETH0_HUMAN: Complement factor I; A0A2R8Y3M9_HUMAN: Uncharacterized protein | ↗ | 371E+07 | 496E+07 | 614E+07 | Immune system |
 ± 873E+06 |  ± 988E+06 |  ± 125E+07 | |||
CD14_HUMAN, D6RFL4_HUMAN: Monocyte differentiation antigen CD14 | ↗ | 971E+06 | 144E+07 | 231E+07 | Inflammation processes |
 ± 229E+06 |  ± 504E+06 |  ± 101E+07 | |||
PRG4_HUMAN, J3KP74_HUMAN: Proteoglycan 4 (Lubricin) | ↗ | 621E+06 | 104E+07 | 176E+07 | Friction reduction |
 ± 232E+06 |  ± 431E+06 |  ± 857E+06 | |||
VWF_HUMAN: von Willebrand factor | ↗ | 281E+06 | 415E+06 | 134E+07 | Blood coagulation cascade |
 ± 103E+06 |  ± 165E+06 |  ± 120E+07 | |||
BTD_HUMAN: Biotinidase | ↗ | 909E+06 | 122E+07 | 149E+07 | Signaling |
 ± 216E+06 |  ± 230E+06 |  ± 340E+06 | |||
A2AP_HUMAN, A0A0G2JPA8_HUMAN, C9JMH6_HUMAN , A0A0J9YY65_HUMAN: Alpha-2-antiplasmin | ↗ | 775E+07 | 105E+08 | 134E+08 | Plasminogen cascade |
 ± 342E+07 |  ± 327E+07 |  ± 354E+07 | |||
Q5VY30_HUMAN, RET4_HUMAN: Retinol-binding protein | ↗ | 145E+08 | 286E+08 | 382E+08 | Vitamin A metabolism |
 ± 421E+07 |  ± 781E+07 |  ± 130E+08 | |||
FINC_HUMAN Fibronectin | ↗ | 105E+08 | 137E+08 | 179E+08 | Plasminogen cascade |
 ± 244E+07 |  ± 396E+07 |  ± 550E+07 |
